Analysis of efficacy, safety and economic comparison of first h. Pylori eradication treatment with a potassium ion-competitive acid blocker and proton pump inhibitors

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: TSUCHIDA, Junnosuke (Kameda Medical Center, Kamogawa, Japan)
  • Co-author(s): Junnosuke Tsuchida:
    Masahito Nakazaki: Department of Pharmacy, Kameda Medical Center, Chiba, Japan
    Kosuke Hashizawa: Department of Pharmacy, Kameda Medical Center, Chiba, Japan
    Ryokan Funakoshi: Department of Pharmacy, Kameda Medical Center, Chiba, Japan
  • Abstract:

    Methods

    Setting the target number of patients at 40, we retrospectively examined, based on medical records, the eradication success rates and safety in patients infected with H. pylori who were treated in our hospital during and after June 2015 with first eradiation therapy for H. pylori, who took in conjunction with Lansoprazole (LPZ), Rabeprazole

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login